Fundraising Fox

Maximon

Venture studio

Zug · Pre-Seed–Series A · 23 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Maximon operates as a company builder centered on the longevity space, empowering entrepreneurs to launch impactful, science-based and scalable ventures. Its focus is on healthy aging and rejuvenation solutions grounded in scientific research.

Invests inBiotechHealthtechLongevityWellness & FitnessEuropeSwitzerlandZug

Source: firm website, verified Jul 31, 2026.

Stage
Pre-Seed–Series A
Check
$11M
HQ
Zug, CH
Instruments
Equity

Team · 23 people

from the firm's website
Caroline Wagner· Founding Partnerin

Caroline Wagner has extensive experience in digital business building and innovation. She was among the first employees and part of the management team at SumUp, and later led cross-functional teams in venture building as a Lead Venture Architect at BCG Digital Ventures in Berlin.

Dr. Tobias Reichmuth· Founding Partnerin𝕏
Jörg Rieker· Founding Partnerin𝕏
Marc P. Bernegger· Founding Partnerin𝕏
Ildikó Sirman· Operating Partnerin
Adrian Locher· Company Building Advisorin𝕏

Adrian Locher is co-founder and CEO of Merantix, a Berlin-based venture studio focused on AI. Over roughly 20 years he has worked as an entrepreneur and investor, founding more than 10 companies in Europe and the US across AI, digital healthcare, and e-commerce, including a Swiss e-commerce firm he sold at EUR 100M in revenue. He holds a degree in business and economics from the University of St. Gallen (HSG).

Cédric Diego Vollmar· Head of Financein
Dalma Riczu· Senior Recruiting & Organizational Development Specialistin

Dalma Riczu holds a Master's degree in Work and Organizational Psychology and has more than five years of Human Resources experience across corporate and agency settings. She has built and managed talent advisory teams focused on the pharmaceutical, biotech, and MedTech industries. Her areas of interest include mental well-being, longevity, and organizational development.

Dr. Aubrey de Grey· Longevity Industry Advisorin𝕏
Dr. Brian Kennedy· Scientific Advisorin𝕏
Dr. Kai Schulze-Wundling· Co-Founder & Chief Medical Officer at Frieda Healthin𝕏

Co-founder and Chief Medical Officer at Frieda Health, a Maximon portfolio company.

Dr. Michael Sidler· Venture Building Advisorin𝕏
Duri Granziol· Co-Founder and CEO at Aveain

Duri Granziol has a background in direct-to-consumer and e-commerce, having co-founded and led Mama's Choice, a D2C brand for mothers and babies in Southeast Asia, and previously serving as Co-CEO of what was then Indonesia's largest e-commerce marketplace. Through consulting work in health insurance and a personal health experience, he developed an interest in preventive health and longevity, and now works in that field as Co-Founder and CEO of Avea.

Lucia Kupcova· Event Manager at Longevity Investors Conferencein𝕏

Lucia Kupcova is an event manager with over 8 years of experience in event and project management across sectors including real estate and international education. She has organized more than 50 B2B and B2G conferences internationally.

Nina Ruge· Advisorin𝕏

Nina Ruge began a television career in 1987 with RIAS TV in Berlin, later appearing on ZDF programs such as "heute journal", "heute Nacht", and "Leute heute", and hosting various talk shows and TV magazines. Since 2021 she has authored several German-language books on cell biology of aging and healthy longevity, all of which reached the SPIEGEL bestseller list. She works primarily as an author focused on the cell biology of aging, gives lectures on healthy longevity, and communicates on the topic through media and social channels.

Pascal Rode· Co-Founder and COO at AVEA𝕏

Pascal Rode is Co-Founder and COO at AVEA. His entrepreneurial background spans fintech and foodtech, where he co-founded and built several companies before moving into longevity and healthtech. Earlier in his career he held senior management roles at large financial corporations, focused on delivering value through technology.

Simona Eicher· Lead Venture Builderin

Simona Eicher works as a Lead Venture Builder at Maximon, focusing on business building and innovation. Before joining the firm, she was at McKinsey & Company, where she led cross-functional teams and helped clients launch new products and implement digital solutions. She holds an MBA from Said Business School at the University of Oxford and a Master's in Management and Economics from the University of Zurich.

Sophie Chabloz· Co-Founder and CPO at AVEAin𝕏

Sophie Chabloz holds an MSc in Food Science, Nutrition & Health from ETH Zürich, where her research examined potential anti-aging molecules in human cells. She has experience in product innovation, development, and commercialization, including work at a large FMCG company and a prior startup. She focuses on functional ingredients and health and wellbeing products.

Teresa Budetta· Co-Founder and CMO at AVEAin𝕏

Teresa Budetta is Co-Founder and CMO at AVEA. She holds a BSc in Finance from Bocconi University and an MSc in International Business from Esade Business School, and began her career in investment banking before moving into marketing. She previously worked at H-Farm Digital Marketing Agency and Mondadori, held content and brand roles at the health company Lykon and at Foodspring, and in 2020 started a consulting agency supporting funded startups with internationalization.

Thanh Schrader-Nguyen· Co-Founder & CPTO, Frieda Healthin

Thanh Schrader-Nguyen has around 10 years of experience in venture building and digital product design and management, with over 5 years in medtech, including German DiGAs where she launched three mental health applications. She has worked at IBM, BCG Digital Ventures, and Selfapy, and previously founded cyclio, a corporate menstrual health benefit company. She is Co-Founder and CPTO of Frieda Health.

Valentina Ullrich· Founder & CEO at Frieda Healthin

Founder and CEO of Frieda Health, a Maximon portfolio company.

Frequently asked questions

What stage does Maximon invest at?
Maximon invests at the Pre-Seed, Seed, Series A stages.
What is Maximon's typical check size?
Maximon typically writes checks of $11M.
What sectors does Maximon focus on?
Maximon focuses on Biotech, Healthtech, Longevity, Wellness & Fitness.
Where is Maximon located?
Maximon is headquartered in Zug, CH.

Media · Podcasts & interviews

featuring the team

Marc P. Bernegger - Founder Maximon: Longevity & Bitcoin (#PE20) - YouTube

Mannheim Investment Club e.V. · Marc P. Bernegger

Images

Maximon photo

Similar investors

Featured in lists